COVID-19 Outcomes in Minority Ethnic Groups: Do Obesity and Metabolic Risk Play a Role?

COVID-19 Ethnic inequalities Metabolic risk Obesity Social determinants of health

Journal

Current obesity reports
ISSN: 2162-4968
Titre abrégé: Curr Obes Rep
Pays: United States
ID NLM: 101578283

Informations de publication

Date de publication:
Sep 2022
Historique:
accepted: 02 09 2021
pubmed: 17 10 2021
medline: 26 8 2022
entrez: 16 10 2021
Statut: ppublish

Résumé

Globally, minority ethnic groups have been at higher risk of COVID-19 mortality and morbidity than majority populations. This review outlines factors that may interact to create these inequalities and explores the hypothesis that differing levels of cardio-metabolic risk, according to ethnic group, play a role. Two UK Biobank studies have reported that the body mass index is more strongly associated with an increased risk of COVID-19 infection and mortality in minority ethnic populations than in White populations. A study of UK patients found that the strongest association between obesity and adverse COVID-19 outcomes was in people of Black ethnicity. Differences in the prevalence of obesity and its metabolic sequelae have been shown to partly mediate ethnic inequalities in COVID-19 outcomes, although not always consistently. It is possible that ethnic differences in the consequences of obesity may explain some of the remaining disparity in COVID-19 risk.

Identifiants

pubmed: 34655051
doi: 10.1007/s13679-021-00459-5
pii: 10.1007/s13679-021-00459-5
pmc: PMC8518892
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-115

Informations de copyright

© 2021. The Author(s).

Auteurs

Paul Coleman (P)

Warwick Medical School, University of Warwick, Coventry, UK.

Thomas M Barber (TM)

Warwick Medical School, University of Warwick, Coventry, UK.

Thijs van Rens (T)

Department of Economics, University of Warwick, Coventry, UK.

Petra Hanson (P)

Warwick Medical School, University of Warwick, Coventry, UK.

Alice Coffey (A)

Warwick Medical School, University of Warwick, Coventry, UK.

Oyinlola Oyebode (O)

Warwick Medical School, University of Warwick, Coventry, UK. o.r.o.oyebode@warwick.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH